CEO: | Adrian Kinkaid |
Chairman: | Simon Gordon Douglas |
Chief Scientific Officer: | Richard John Buick |
Non-Executive Dir: | Colin Walsh, Matthew Baker |
Address: | Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast, United Kingdom, BT17 0QL |
Website: | https://www.fusionantibodies.com/ |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BDQZGK16 |
Currency | UK Pounds |
Share Price | 15.75p |
Change Today | 1.00p |
% Change | 6.78 % |
52 Week High | 17.50 |
52 Week Low | 2.95 |
Volume | 345,726 |
Shares Issued | 113.66m |
Market Cap | £17.90m |
RiskGrade | 464 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
11:51 | 8 @ 15.75p |
10:43 | 69,615 @ 15.29p |
11:26 | 9,000 @ 15.75p |
11:22 | 4 @ 15.80p |
10:54 | 150,000 @ 15.13p |
Chair | Simon Gordon Douglas |
CEO | Adrian Kinkaid |
You are here: research